Factores de riesgo para el síndrome metabólico en una población con apnea del sueño; evaluación en un grupo de pacientes de Granada y provincia; estudio GRANADA

Valenza, Ma. C.; Martín, L. Martín; Jiménez, E. González; Cordero, Ma. J. Aguilar; López, M. Botella; Casaubon, T. Muñoz; Demet, G. Valenza
July 2012
Nutricion Hospitalaria;2012, Vol. 27 Issue 4, p1255
Introduction: The Metabolic Syndrome is one of the first health problems in the public health of the century. It's consider that the beginning of the syndrome is determined by numerous factors that developed two main metabolic disturbances: the insulin resistance and the central obesity. This relationship is concentrating the scientific world. As the cause-effect relationship has to be answered, the epidemiologic research has focused on without results. Material and methods: 1,016 subjects were recruited in the sleep disorders laboratory in San Cecilio Hospital with sleep apnea suspicion. Results: Significant correlation (p < 0,001) was found between sleep apnea severity and nocturnal saturation values and the different metabolic disturbances related to the metabolic syndrome (Hypertension, Diabetes and obesity). By the contrary, we doesn't found significant differences between No-Sleep apnea group and moderate sleep apnea group in the majority of the variables. Conclusions: Subjects with sleep apnea have significantly more possibilities to develop metabolic syndrome, and cardiovascular pathology. These subjects had to be evaluated in this sense to reduce the impact associated to this pathology.


Related Articles

  • Nutrición, síndrome metabólico y obesidad mórbida. Ruano Gil, M.; Silvestre Teruel, V.; Aguirregoicoa García, E.; Criado Gómez, L.; Duque López, Y.; García-Blanch, G. // Nutricion Hospitalaria;jul/ago2011, Vol. 26 Issue 4, p759 

    Introduction: Obesity, and specifically morbid obesity (MO), is a chronic disease with serious health consequences related to the associated comorbidities and constitutes a leading risk factor for the metabolic syndrome (MS) and cardiovascular disease (CVD). In the present study we analyze the...

  • Is sleep-disordered breathing an additional risk factor for the metabolic syndrome in obese children and adolescents? Verhulst, S. L.; Rooman, R.; Van Gaal, L.; De Backer, W.; Desager, K. // International Journal of Obesity;Jan2009, Vol. 33 Issue 1, p8 

    Sleep-disordered breathing is highly prevalent in childhood obesity. Two recent cross-sectional studies have demonstrated an independent association between the severity of sleep-disordered breathing and the metabolic syndrome. A limited number of studies have also addressed the correlation...

  • Inflammation as a Link between Obesity and Metabolic Syndrome. Emanuela, Faloia; Grazia, Michetti; Robertis Marco, De; Paola, LuconiMaria; Giorgio, Furlani; Marco, Boscaro // Journal of Nutrition & Metabolism;2012, p1 

    The metabolic syndrome is a complex of clinical features leading to an increased risk for cardiovascular disease and type 2 diabetes mellitus in both sexes. Visceral obesity and insulin resistance are considered the main features determining the negative cardiovascular profile in metabolic...

  • Significance of vaspin in obstructive sleep apnea-hypopnea syndrome. ZHE PAN; XIANGHUA ZHUANG; XIAOBO LI; SHAOYI HUANG; LIANG ZHANG; FUCHEN LOU; SHIHONG CHEN; YIHONG NI // Experimental & Therapeutic Medicine;Mar2016, Vol. 11 Issue 3, p841 

    Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a commonly-diagnosed chronic sleep disorder. It is considered to be an important independent risk factor in the development of insulin resistance (IR). Patients with OSAHS exhibit a variety of metabolic disorders, including obesity and...

  • Prevalence of Abdominal Obesity in Adolescents 2012, Birjand, East of Iran. Taheri, Fatemeh; Chahkandi, Tayebeh; Kazemi, Toba; Namakin, Kokab; Zardast, Mahmoud; Bijari, Bita // International Journal of Preventive Medicine;Sep2014, Vol. 5 Issue 9, p1198 

    Background: Prevalence of obesity in children has been increased during recent decades all over the world. Obesity, particularly, abdominal obesity (AO) is associated with the risk of metabolic syndrome and cardiovascular disease. This study aimed to assess obesity and central obesity within...

  • Metabolic syndrome and the menopause. Kaaja, Risto J. // Menopause International;Mar2008, Vol. 14 Issue 1, p21 

    The metabolic syndrome consists of a combination of risk factors that include abdominal obesity, atherogenic dyslipidaemia, hypertension and insulin resistance. It increases the risk of cardiovascular disease and type 2 diabetes. The increased risk of cardiovascular disease is higher in women...

  • ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Noctor, Eoin; Crowe, Catherine; Carmody, Louise; Kirwan, Breda; O'Dea, Angela; Glynn, Liam; McGuire, Brian; O'Shea, Paula; Dunne, Fidelma // Acta Diabetologica;Feb2015, Vol. 52 Issue 1, p153 

    Women with previous gestational diabetes (GDM) are a high-risk group for future development of diabetes, metabolic syndrome, and cardiovascular disease. The new International Association of Diabetes in Pregnancy Study Groups (IADPSG) criteria significantly increase the number of women diagnosed...

  • The Real Scoop on Sugar. Palmer, Sharon // Today's Dietitian;Oct2012, Vol. 14 Issue 10, p28 

    The article discusses whether consumption of sugar has negative effects on health. For many years healthcare community is warning people that too much consumption of sugar-related products causes obesity and subsequently leads to type 2 diabetes. However, recent studies have shown that sugar is...

  • OSA, obesity and metabolic dysregulation: Growing links. Taheri, Shahrad // Diabetes Digest;2011, Vol. 10 Issue 3, p152 

    The article focuses on the association between obstructive sleep apnoea (OSA) and metabolic abnormalities in obese people. It mentions that continuous positive airway pressure (CPAP) is a treatment option for OSA. It notes that interaction between metabolism and OSA can be mediated by several...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics